Back to top

hospitals: Archive

Shaun Pruitt

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Shares of Moderna (MRNA) and Merck (MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their personalized mRNA cancer vaccine.

MRKPositive Net Change MRNAPositive Net Change